Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.
ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
ENYO Pharma is a biopharmaceutical company based in Lyon, France.
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.
RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.
Lomond Therapeutics creates pharmacological platforms that target escape mutations.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.
Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.
Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
OrbiMed has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 12 different industry categories.
Among tracked funding rounds, Verdiva Bio received $411.0M in a Series A round. OrbiMed's total known invested capital is $31.2B.
OrbiMed's average investment size is $108.2M across its portfolio of 288 companies.
Recent OrbiMed portfolio additions include Avenzo Therapeutics, Treeline Biosciences, ProVerum Medical, Rhythm Pharmaceuticals, Renasant Bio. These companies were founded in 2020 or later.